Felix Hilpert
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Treatment and outcome of elderly patients with presumed early ovarian cancer in Germany: real-world observations from the quality-assurance program of the AGO Study Group.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 13, 2026
How the ionic liquid [C2C1Im][OTf] affects the stability of Pt(111) during potential cycling.
Journal: Physical chemistry chemical physics : PCCP
Published: June 05, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 23, 2025
Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 30, 2025
Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group - Real-world observations.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: December 03, 2024
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis.
Journal: International journal of surgery (London, England)
Published: November 30, 2024
Prognostic significance and accuracy of oncologists' estimates of survival time in recurrent ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 08, 2024
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: September 06, 2024
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: July 25, 2024
Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
Journal: Gynecologic oncology
Published: January 23, 2024
Last Updated: 09/26/2026